Jounce Therapeutics to Present at Upcoming Investor Conferences in September
CAMBRIDGE, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient enrichment, today announced …